top of page
Search
Side Effects Linked with Immunotherapy Targeting Checkpoints
Background: The blockade of immune regulatory sites, CTLA-4, PD-1, and PD-L1 with Immune Checkpoint Inhibitors has revolutionized...
Trends in Acute Kidney Injury Incidence, Causes, and Outcomes in Patients on Immune Checkpoint Inhib
Abstract Background and objectives: Immune checkpoint inhibitor (ICI) use is increasing in the United States, real world data on acute...
bottom of page